Touyun Biotech Group Limited

SEHK:1332 Rapporto sulle azioni

Cap. di mercato: HK$477.0m

Touyun Biotech Group Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amy Ha

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO2.8yrs
Proprietà del CEOn/a
Durata media del management5.3yrs
Durata media del Consiglio di amministrazione7.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Sep 15
Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jul 17
Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Apr 22
Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

Apr 08
Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Feb 07
What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Dec 18
Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

Sep 19
Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

Jul 28
Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Sep 13
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

May 18
Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Dec 24
Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

Mar 12
Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

Jan 15
If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

Jan 15
The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

Dec 11
How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

AMMINISTRATORE DELEGATO

Amy Ha (52 yo)

2.8yrs

Mandato

Ms. Amy Ha (Former name: Ha Man) is Chief Executive Officer of Touyun Biotech Group Limited from January 03, 2022. She has extensive experiences in the financial management and investment. From April 1998...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Liang Wang
Executive Chairman8.2yrsHK$3.60m27.35%
HK$ 130.5m
Dong Du
Executive Director7.9yrsHK$1.22mNessun dato
Amy Ha
Chief Executive Officer2.8yrsNessun datoNessun dato
On Lok Li
Company Secretary2.3yrsNessun datoNessun dato

5.3yrs

Durata media

41.5yo

Età media

Gestione esperta: Il team dirigenziale di 1332 è esperto e expertise (durata media dell'incarico 5.3 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Liang Wang
Executive Chairman8.2yrsHK$3.60m27.35%
HK$ 130.5m
Dong Du
Executive Director7.9yrsHK$1.22mNessun dato
Shing Chuen To
Independent Non-Executive Director10yrsHK$248.00kNessun dato
Kee Choy Ha
Independent Non-Executive Director10yrsHK$248.00kNessun dato
Wing Ping Cheung
Independent Non-Executive Director9.3yrsHK$248.00kNessun dato
Hui Chen
Non-Executive Director7.9yrsHK$240.00kNessun dato
Guohua Hu
Independent Non-Executive Director4yrsHK$100.00kNessun dato
Yuze Tian
Non-Executive Director4.6yrsHK$120.00k5.2%
HK$ 24.8m
Lele Zhang
Non-Executive Director4yrsHK$978.00kNessun dato
Wenjie Jia
Non-Executive Director4yrsHK$20.00k0.036%
HK$ 170.0k

7.9yrs

Durata media

44.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1332 sono considerati esperti (durata media dell'incarico 7.9 anni).